
HIV in Nigeria remains a significant public health challenge that demands comprehensive understanding and action. With approximately 1.9 million people living with HIV across the country, Nigeria has the largest HIV epidemic in West and Central Africa. However, there’s encouraging progress: Nigeria has achieved two of the three global 95-95-95 HIV targets as of 2025, with 87% of people living with HIV knowing their status, 98% of those on treatment, and 95% achieving viral suppression. This demonstrates that with proper care and modern antiretroviral therapy, people living with HIV can lead long, healthy lives.
This comprehensive guide provides essential information about HIV statistics, symptoms at different stages, treatment protocols, and how to access care throughout Nigeria. Whether you’re seeking information for yourself, a loved one, or simply want to stay informed, understanding HIV in Nigeria empowers better health decisions.
HIV (Human Immunodeficiency Virus) attacks the body’s immune system, specifically targeting CD4 cells that help fight infections. Without treatment, HIV can progress to AIDS (Acquired Immunodeficiency Syndrome), the most advanced stage where the immune system becomes severely compromised.
The good news is that HIV is no longer a death sentence. Modern antiretroviral therapy allows people living with HIV to maintain healthy immune systems and live normal lifespans. The key is early detection and consistent treatment.
Nigeria’s national HIV prevalence stands at 1.4% among adults aged 15-49 years, with an estimated 1.9 million people living with HIV. While this represents significant progress from earlier estimates of 2.8%, the country must continue efforts to reach everyone who needs testing and treatment.
According to 2024 data from the World Health Organization, approximately 2 million people in Nigeria have HIV, including both adults and children. The National Agency for the Control of AIDS (NACA) Director-General, Dr. Temitope Ilori, announced in December 2025 that Nigeria has achieved remarkable progress, with 87% of people living with HIV knowing their status, 98% of those who know their status receiving treatment, and 95% of those on treatment achieving viral suppression.
Women face disproportionate risk, with HIV prevalence of 1.9% compared to 0.9% among men. Young women aged 20-24 are more than three times as likely to be living with HIV as young men in the same age group. This gender disparity reflects broader issues of inequality, gender-based violence, and power imbalances in relationships.
In 2021, 14,000 young women aged 15-24 acquired HIV, compared to just 3,600 young men, highlighting how gender inequality drives infection rates.
HIV prevalence varies dramatically across Nigeria’s geographic zones:
The South-South zone has the highest HIV prevalence at 3.1% among adults aged 15-49 years, followed by the North Central zone at 2.0% and the South East zone at 1.9%. The North West zone reports the lowest prevalence at 0.6%.
States with the highest burden include Rivers State with 208,767 cases, Benue State with 202,346 cases, Akwa Ibom with 161,597 cases, and Lagos State with 108,649 cases as Nigeria’s commercial hub.
HIV infections have fallen by 39% since 2010, demonstrating the effectiveness of prevention and treatment programs. HIV prevalence has reduced from 4.1% in 2010 to 1.4 in 2019, with new infections decreasing from 120,000 in 2010 to 74,000 in 2021, and HIV-related deaths dropping from 82,000 to 51,000 during the same period.
However, challenges remain. Nigeria has the highest number of annual HIV infections among children in the world, accounting for 14% of the global total. Between 2010 and 2020, Nigeria reduced mother-to-child transmission by only 15%, compared to 70% reductions in countries like South Africa and Uganda.
In 2024 alone, 204,201 individuals from key populations were actively receiving antiretroviral therapy with strong viral suppression rates, demonstrating progress in reaching vulnerable groups.
HIV spreads through specific bodily fluids including blood, semen, vaginal fluids, rectal fluids, and breast milk. The main transmission routes in Nigeria include:
Unprotected Sexual Contact: The most common transmission route, particularly through vaginal or anal intercourse without consistent condom use.
Sharing Needles and Syringes: Provides direct blood-to-blood contact when people inject drugs using contaminated equipment.
Mother-to-Child Transmission: Without intervention, HIV can pass from mother to child during pregnancy, childbirth, or breastfeeding. Prevention programs can reduce this risk significantly.
Blood Transfusions: While rare in modern healthcare settings with proper screening, unsafe blood transfusions can transmit HIV.
Several factors increase HIV risk in Nigeria:
Only 34% of young men and 43% of young women have comprehensive knowledge about HIV prevention, highlighting critical gaps in education.
HIV prevalence among sex workers in Nigeria is approximately 14%, the highest among key populations, while around 23% of men who have sex with men are estimated to have HIV. These populations face additional barriers due to criminalization and stigma.
Understanding what doesn’t transmit HIV is equally important:
Acute HIV infection is the earliest stage and generally develops within 2 to 4 weeks after infection with HIV. During this time, some people have flu-like symptoms such as fever, headache, and rash. About two-thirds of people will have flu-like symptoms within 2 to 4 weeks after HIV infection, lasting anywhere from a few days to several weeks. Some people don’t have any symptoms at all during this early stage.
Common symptoms during acute infection include:
Critical Importance of Early Detection: During the acute stage, the level of HIV in the blood is very high, which greatly increases the risk of HIV transmission. Getting tested and starting treatment during this stage offers the best long-term health outcomes.
If you think you may have been exposed to HIV, get an HIV test whether you have symptoms or not. When you are in the early stage of infection, you are at very high risk of transmitting HIV to others.
During chronic HIV infection, HIV continues to multiply in the body but at very low levels. People with chronic HIV infection may not have any HIV-related symptoms. Without antiretroviral therapy, chronic HIV infection usually advances to AIDS in 10 years or longer, though in some people it may advance faster.
According to HIV.gov, latency in HIV infection can last up to 10 or 15 years. During this asymptomatic period, people may experience:
Even without symptoms, the virus actively damages the immune system and remains transmissible to others. Regular medical monitoring of CD4 counts and viral load becomes essential during this stage.
A CD4 count below 200 cells per cubic millimeter (compared to the normal range of 500-1,600 cells/mm³) indicates AIDS progression. Without treatment, HIV eventually progresses to AIDS when the immune system becomes severely compromised.
Symptoms of advanced HIV/AIDS include:
People with AIDS become vulnerable to opportunistic infections—diseases that typically don’t cause severe illness in people with healthy immune systems but can be life-threatening for those with compromised immunity.

Several testing methods are available throughout Nigeria:
Rapid Antibody Tests: Provide results within 20-30 minutes using a finger prick blood sample or oral swab. These tests detect antibodies the body produces in response to HIV infection.
Laboratory-Based Tests: More comprehensive tests conducted at medical facilities, typically providing results within 1-3 days with higher accuracy.
Self-Testing Kits: The availability of HIV self-testing kits increased by 20% in Nigeria in 2022, improving testing rates. These allow private testing at home with results in 15-20 minutes.
Antigen/Antibody Combination Tests: Detect both HIV antibodies and p24 antigen, allowing earlier detection than antibody-only tests.
The proportion of Nigerians tested for HIV at least once in their lifetime increased from 35% in 2018 to 45% in 2022. HIV testing is widely available across Nigeria through:
The National Agency for the Control of AIDS (NACA) website maintains updated directories of testing locations across all 36 states.
The “window period” refers to the time between HIV exposure and when tests can reliably detect the infection. Different tests have different window periods, so timing matters for accurate results.
If you test negative but had recent exposure, retesting after the window period ensures accuracy. All reactive (positive) tests require confirmatory testing to ensure accuracy before diagnosis.
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral drugs to maximally subdue the HIV virus and stop the progression of HIV disease. ART has transformed HIV from a fatal diagnosis into a manageable chronic condition.
How ART Works: These medications prevent HIV from replicating, allowing the immune system to recover and maintain strength. With consistent treatment, people with HIV who maintain an undetectable viral load through treatment cannot sexually transmit the virus to partners. People who take HIV medicine as prescribed can live long and healthy lives.
This concept, known as U=U (Undetectable = Untransmittable), has been confirmed through multiple large scientific studies and represents a revolution in HIV treatment and prevention.
Nigeria follows World Health Organization (WHO) guidelines for HIV treatment. First-line regimens typically combine three antiretroviral drugs from at least two different classes:
These fixed-dose combinations simplify treatment by combining multiple medications into a single daily pill, making adherence easier.
Nigeria has adopted a “test and treat” policy, meaning anyone diagnosed with HIV should start treatment immediately, regardless of CD4 count. This approach offers the best health outcomes and prevents transmission.
After starting ART, most people experience:
Research trials found that there was a 53% reduction in the risk of death or serious illness if treatment was started with a high CD4 cell count, emphasizing the importance of early treatment initiation.
Regular monitoring includes viral load tests every 6 months and CD4 count checks to ensure treatment effectiveness.
While modern HIV medicines have fewer side effects than earlier treatments, some people experience temporary issues:
Most side effects resolve within the first few weeks as your body adjusts. Never stop taking medication without consulting your healthcare provider, as this can lead to drug resistance and disease progression.
Pre-Exposure Prophylaxis (PrEP): Daily medication for HIV-negative people at high risk of infection. When taken consistently, PrEP reduces the risk of getting HIV from sex by about 99%. PrEP is increasingly available in Nigeria, though access remains limited compared to treatment.
Post-Exposure Prophylaxis (PEP): Emergency medication taken within 72 hours after potential HIV exposure. PEP involves taking antiretroviral medicines for 28 days to prevent infection. The sooner you start PEP after exposure, the more effective it is.
Both prevention methods are available through major treatment centers, though scaling up access remains a priority.

The Federal government of Nigeria introduced the national ART programme in 2002, and by 2006, started a program with the goal of providing ARV drugs at no cost to about 250,000 HIV-positive patients. The program has since expanded significantly.
When global funding uncertainties threatened services, the federal government injected $200 million to ensure uninterrupted delivery of HIV prevention, testing, and treatment services. This demonstrates Nigeria’s commitment to sustaining its HIV response despite external funding challenges.
The National AIDS Control Programme, managed by NACA, coordinates HIV response efforts across all 36 states. Through PEPFAR’s support, more than 1.6 million Nigerians out of an estimated two million living with HIV now have access to antiretroviral treatment.
National Agency for the Control of AIDS (NACA): The coordinating body for Nigeria’s HIV response. NACA provides policy direction, coordinates stakeholders, and manages the national program. Visit naca.gov.ng for information and resources.
AIDS Healthcare Foundation (AHF) Nigeria: Operating since 2011, AHF Nigeria has conducted more than 2.5 million HIV tests and provides free ART, TB/HIV co-infection management, and comprehensive care. Contact: +234 9050837511 or visit facilities in Abuja and Benue.
Society for Family Health (SFH): One of Nigeria’s largest implementing partners, SFH operates One-Stop Shops providing integrated HIV services including testing, counseling, STI treatment, and ART for key populations. They work extensively in Lagos, Akwa Ibom, and FCT.
Institute of Human Virology Nigeria (IHVN): Implements the AIDS Care and Treatment in Nigeria (ACTION) program, providing comprehensive care at tertiary and secondary health facilities across multiple states.
CDC-Supported Facilities: The U.S. Centers for Disease Control and Prevention supports HIV programs in high-burden states including Akwa Ibom, Lagos, Rivers, Benue, and Cross River.
Lagos State (Nigeria’s Commercial Hub):
Abuja (Federal Capital Territory):
High-Prevalence States:
Connecting with others living with HIV provides emotional support and practical guidance. Support groups operate through:
NACA has strengthened integration of HIV services into wider health systems and expanded enrollment of people living with HIV into state health insurance schemes, making comprehensive care more accessible.
Free Services Available:
Patient Rights: Nigeria’s HIV Anti-Discrimination Act (2014) protects people living with HIV from discrimination in employment, healthcare, and education. Your HIV status remains confidential, and healthcare providers cannot disclose your status without consent.
If you face discrimination or need legal support, organizations like NEPWHAN provide advocacy services and can connect you with legal resources.

Good nutrition supports immune function and helps your body respond to treatment effectively. Focus on:
Living with HIV affects mental health in various ways. Common challenges include:
The People Living With HIV Stigma Index (2021) found 20% of people with HIV had experienced HIV-related stigma in the past 12 months, while around 60% of Nigerians hold discriminatory attitudes toward people with HIV. This stigma can significantly impact mental health.
Counseling services, available at most treatment centers, provide essential support. Don’t hesitate to request mental health services—they’re as important as physical health care. Many facilities now offer integrated mental health support alongside HIV treatment.
Deciding when and how to disclose your HIV status remains deeply personal. Consider:
Remember: When viral load is undetectable through consistent treatment, the risk of sexual transmission becomes negligible (U=U: Undetectable = Untransmittable). This scientific fact can provide reassurance when navigating relationships.
People living with HIV can have healthy children through:
New HIV infections among children under 5 in Nigeria decreased by 35% between 2017 and 2022, due to improved PMTCT programs. With proper medical care and viral suppression, transmission rates can drop below 2% in well-resourced programs.
Ending the HIV epidemic requires community-level interventions:
New HIV infections declined by only 46% from 2010 to 2023 compared to a target of 80%, indicating that prevention efforts need strengthening. Only 3% of AIDS expenditure in Nigeria in 2019 was on HIV prevention, compared to 27% of global AIDS expenditure on prevention, highlighting the need for increased investment in prevention strategies.
Currently, there is no cure for HIV. However, antiretroviral therapy effectively controls the virus, allowing people to live long, healthy lives. Research shows that people who start HIV treatment early can live as long as people who do not have the virus, largely due to the advancement of HIV medicines. Scientists continue researching potential cures, including stem cell therapies and gene editing, but ART remains the standard, highly effective treatment.
With early diagnosis and consistent treatment, people with HIV can expect near-normal life expectancy. Studies show that people starting treatment early with good adherence can live as long as HIV-negative individuals of similar age. The key factors are early detection, immediate treatment initiation, and excellent medication adherence.
Yes, the Nigerian government provides free antiretroviral therapy at designated public health facilities nationwide. Testing, counseling, and basic laboratory monitoring are also available at no cost through government programs and partner organizations. The Federal government heavily subsidizes the price of drugs with help from several donor agencies.
Absolutely. With proper medical care and viral suppression, people living with HIV can safely conceive and have healthy, HIV-negative children. The proportion of HIV-positive pregnant women receiving ART to prevent mother-to-child transmission increased to 87% in 2022. Prevention of mother-to-child transmission programs have reduced transmission rates significantly when protocols are followed consistently.
Testing frequency depends on your risk factors:
The proportion of Nigerians tested for HIV at least once in their lifetime increased from 35% in 2018 to 45% in 2022, but many more people still need to know their status.
Missing doses can lead to drug resistance, making your current medication less effective or ineffective. If you miss a dose, take it as soon as you remember unless it’s almost time for the next dose. Never double up on doses. Contact your healthcare provider if you frequently miss doses—they can help develop adherence strategies, adjust your regimen, or address barriers to consistent medication taking.
Yes, absolutely. Nigerian law protects people living with HIV from workplace discrimination. You don’t need to disclose your status to employers, and HIV status cannot be grounds for dismissal or refusal to hire. Many people with HIV maintain successful, productive careers while managing their health effectively.
No. Scientific evidence confirms that people with HIV who maintain an undetectable viral load through consistent treatment cannot sexually transmit the virus to partners. This concept, known as U=U (Undetectable = Untransmittable), has been confirmed through multiple large studies involving thousands of couples. However, maintaining consistent treatment and regular monitoring is essential to keep viral load undetectable.
Focus on a balanced diet rich in fruits, vegetables, whole grains, lean protein, and healthy fats. Avoid undercooked meat, raw eggs, unpasteurized dairy products, and unwashed fruits and vegetables, as your immune system may be more vulnerable to foodborne illnesses. Stay well-hydrated, limit alcohol consumption, and avoid excessive sugar and processed foods. Good nutrition supports your immune system and helps medications work effectively.
Ask your healthcare provider about hospital-based support groups. Organizations like NEPWHAN, AHF Nigeria, and state AIDS control agencies coordinate support groups across Nigeria. Many facilities also offer peer counseling programs connecting newly diagnosed individuals with experienced mentors. Online communities and WhatsApp groups provide additional support options for those who prefer virtual connections.
Nigeria has made remarkable strides in addressing HIV over the past decade. Nigeria has achieved two of the three global 95-95-95 HIV targets, marking a major milestone in its national response. HIV prevalence has reduced from 4.1% in 2010 to 1.4 in 2019, new infections decreased from 120,000 in 2010 to 74,000 in 2021, and HIV-related deaths dropped from 82,000 in 2010 to 51,000 in 2021.
However, significant work remains. Dr. Temitope Ilori acknowledged that Nigeria still faces persistent stigma and discrimination, heavy reliance on external funding, a high pediatric HIV burden, and underserved hard-to-reach areas. Addressing these challenges requires sustained commitment, increased domestic financing, and community engagement.
Dr. Ilori pledged that Nigeria will scale up domestic financing, expand access to PrEP, accelerate efforts to eliminate mother-to-child transmission, and intensify prevention services for key and vulnerable groups. The country has announced plans to begin domestic production of HIV commodities, including test kits and antiretroviral drugs, to strengthen self-reliance and sustainability.
Innovation is gaining momentum with lenacapavir, a new long-acting medicine that can prevent HIV infection with twice-a-year injections, offering a transformative opportunity in high-burden settings like Nigeria.
If you’re living with HIV, know that you can lead a full, healthy, productive life. Modern treatment is highly effective, and with proper care, your HIV diagnosis doesn’t define your future. Connect with healthcare providers, join support communities, and stay committed to your treatment plan.
If you’re HIV-negative, protect yourself through consistent prevention methods, regular testing, and comprehensive knowledge. Consider whether PrEP might be right for you if you face higher risk. Support friends and family members living with HIV by reducing stigma and providing compassionate understanding.
Everyone plays a role in ending HIV stigma and transmission. Compassion, accurate information, and support for people living with HIV strengthen our communities and advance progress toward ending the epidemic.
National Contacts:
International Resources:
View all